SCTB-14
- Generic Name
- SCTB-14
Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB14 in Adult Patients With Advanced Malignant Solid Tumours.
- First Posted Date
- 2024-03-12
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 515
- Registration Number
- NCT06304818
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath